Charles Carroll Financial Partners LLC Has $218,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Charles Carroll Financial Partners LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 38.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,765 shares of the pharmacy operator’s stock after selling 1,700 shares during the period. Charles Carroll Financial Partners LLC’s holdings in CVS Health were worth $218,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of CVS. Bryn Mawr Capital Management LLC grew its stake in shares of CVS Health by 74.0% in the third quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock valued at $3,017,000 after buying an additional 18,385 shares in the last quarter. Value Partners Investments Inc. raised its holdings in shares of CVS Health by 26.5% in the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock valued at $69,261,000 after purchasing an additional 207,702 shares during the period. Sonora Investment Management Group LLC lifted its stake in CVS Health by 1.6% in the 3rd quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock valued at $3,525,000 after purchasing an additional 774 shares during the last quarter. Checchi Capital Advisers LLC increased its position in CVS Health by 2.3% during the third quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock worth $726,000 after buying an additional 233 shares during the last quarter. Finally, Personal CFO Solutions LLC raised its stake in CVS Health by 2.6% in the third quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock valued at $1,351,000 after buying an additional 491 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CVS has been the subject of several research analyst reports. Cantor Fitzgerald downgraded CVS Health from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $87.00 to $58.00 in a research note on Wednesday. Bank of America cut their target price on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research note on Thursday. Royal Bank of Canada lowered their price target on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Piper Sandler upped their target price on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, March 15th. Finally, UBS Group cut CVS Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $85.00 to $60.00 in a report on Thursday. Eight research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $80.35.

Insider Activity

In other CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the acquisition, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Edward J. Ludwig acquired 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at $3,059,916.75. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

CVS Health Price Performance

NYSE CVS traded up $0.75 during trading on Friday, hitting $55.90. 23,946,075 shares of the company’s stock were exchanged, compared to its average volume of 12,498,538. The stock’s 50 day moving average price is $72.77 and its two-hundred day moving average price is $73.26. CVS Health Co. has a fifty-two week low of $53.70 and a fifty-two week high of $83.25. The company has a current ratio of 0.81, a quick ratio of 0.63 and a debt-to-equity ratio of 0.78. The company has a market cap of $70.18 billion, a PE ratio of 9.82, a P/E/G ratio of 0.88 and a beta of 0.56.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The company had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.20 EPS. Research analysts expect that CVS Health Co. will post 7.03 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.76%. CVS Health’s dividend payout ratio is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.